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Accepted 1 January 2013Objective. Fuel oxidation during exercise was studied in type 1 insulin-dependent (T1DM)
patients mainly under quite constant insulin and glycemia; these protocols, however, likely
do not reflect patients’ usual metabolic conditions. The glucose oxidation rate (GLUox) in
T1DM patients under usual life conditions was thus investigated during prolonged exercise
(3-h) and its behavior was described mathematically.
Materials/Methods. Whole-body GLUox was determined in eight T1DM patients (4/8 M;
aged 35–59 years) and eightwell-matchedhealthy subjects. Venous bloodwas drawnprior to
and every 30 min until the end of exercise; glycemia, insulin, cortisol, and growth hormone
concentrations were determined. Oxygen consumption, carbon dioxide production, and
ventilation were measured at rest and thereafter every 30 min of the exercise. To prevent
hypoglycemia, patients were given fruit fudge (93% sucrose) prior to / during exercise.
Results. Insulin concentration and glycemia were significantly higher in patients across
the entire exercise period (group effect, p<0.001 for both). GLUox decreased significantly
with increasing exercise duration (time effect, p<0.001), but no significant difference was
detected between the two groups (group effect, p=NS). GLUox, expressed as the percentage
of the starting value, was described by an exponential function showing a time constant of
90 min (n=96; mean corrected R2=0.666).
Conclusions. GLUox in T1DM patients was not significantly different from the rate
observed in the control subjects. The function describing the time course of GLUox may be
useful to correct an estimated GLUox for the duration of exercise and help T1DM patients
avoiding exercise-induced glycemic imbalances.
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4dependent diabetes (T1DM) because of its numerous benefi-
cial effects [1,2]. In particular, exercise has protective effects
against several cardiovascular risk factors [3–5], improves
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Table 1 – Characteristics of the study groups.
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metabolic control [1,8]. Furthermore, exercise can enhance
psychological well-being by increasing self-esteem and qual-
ity of life [9].
However, fear of exercise-induced hypoglycemia often
discourages T1DM patients from regular physical activities
[10,11]. Several strategies have been proposed to counter an
excessive exercise-induced fall of glycemia, especially during
moderate intensity exercise, with the more recent one being
the performance of intermittent high-intensity exercise [12–
15] or the association with a single bout of resistance exercise
[16]. The most commonly suggested countermeasure to
oppose the exercise-induced fall of glycemia, however, is
additional glucose ingestion [17–22], especially when exercise
is spontaneous and not planned in advance [23,24]. Never-
theless, current guidelines to minimize the risk of early onset
of exercise-related glycemic imbalances in T1DM patients
have been mainly drawn on the basis of short duration
exercises (up to 60 min) [20,25–34]. In contrast, several outdoor
leisure time physical activities (e.g., hiking, hill walking,
biking, cross-country skiing), although light to moderate in
intensity, tend to be prolonged in time.
Our workgroup has recently proposed an algorithm [21,35],
which estimates the amount of carbohydrates (CHO) required
by a T1DM patient to minimize the risk of exercise-induced
glycemic imbalances. The keystone of the algorithm is the
estimate of the amount of CHO oxidized during the effort on
the basis of heart rate (HR), taken as an index of exercise
intensity [36]. The fuel oxidation rates during exercise were
studied in T1DM patients mainly under constant insulin
infusion rate and quite constant glycemia [14,37–40]. Un-
doubtedly, these experimental protocols allow to carefully
control several parameters that are likely to affect metabo-
lism. However, exercise metabolism under patients’ usual life
conditions (i.e., insulin doses and orally administered CHO) is
less studied [36,41], particularly during prolonged exercises. In
addition, although a time-dependent decrease in the whole-
body CHO oxidation rate has been observed in healthy people
[42–50], no mathematical equations have ever been proposed
to describe this behavior.
The present study thus aimed at investigating the time
course of whole-body CHO oxidation rate during prolonged
(3-h) exercise in a group of type 1 insulin-dependent patients
under usual life conditions. In addition, a comparison with
the time course of CHO oxidation rate in well-matched
healthy controls was also performed. The secondary aim of
the study was to mathematically describe the behavior of
glucose oxidation rate (GLUox) as a function of exercise
duration. This function might be introduced in the algorithm
proposed by our workgroup [21,35], thus enhancing its
performance for prolonged exercises.Diabetic Patients Control Subjects
Age (years) 45±9 42±12
Body mass (kg) 71.6±14.5 73.0±12.7
Stature (m) 1.69±0.09 1.73±0.05
Body Mass Index (kg/m2) 25.0±3.2 24.3±3.4
Illness duration (years) 27.9±15.3 –
HbA1c (%) 7.2±1.2 5.9±0.4 ⁎
⁎ Significantly lower than the values of T1DM patients (p<0.05).2. Methods
2.1. Subjects
Eight type 1 diabetic patients (4 men and 4 women; aged 35 to
59 years, and diagnosed with diabetes since 5 to 49 years)
volunteered to be subjects. A control group of 8 well-matchedhealthy subjects (4 males and 4 females) was also studied. All
the subjects practiced aerobic physical exercise regularly, but
none was highly trained. We were aware of the fact that
women rely more on fat oxidation than men [51–54] and that
the hormonal status in females might influence substrate
utilization [55–57]. It was thus expected that the heterogeneity
in the two groups of volunteers may introduce some noise in
the results. The patients were accepted if they were not
affected by other chronic diseases and had no evidence of
diabetes complications contraindicating physical activity. The
physical and clinical characteristics of the two study groups
are summarized in Table 1.
All the participants were informed of the nature, purpose,
and possible risks involved in the study before giving their
voluntary written consent to participate in this study. The
study was approved by the Ethical Committee of the
University of Udine and was conducted according to the
principles expressed in the Declaration of Helsinki.
2.2. Experimental protocol
All the volunteers were asked to refrain from strenuous
physical activity, alcohol, and caffeine during the 24-h period
preceding the experimental session. In addition, the patients
were advised to maintain their usual diet and insulin regimen
and carefully control their blood glucose levels according to
the self-management procedures to avoid the occurrence of
hypoglycemic events.
All volunteers arrived at the laboratory early in the
morning. At 7:30 AM, the T1DM patients injected themselves
with their usual insulin dose (0.08±0.04 IU·kg−1) subcutane-
ously in the abdomen wall and consumed their usual
breakfast, which included 0.6±0.2 g·kg−1 of CHO in the form
of starch. Immediately thereafter, a care-provider inserted the
sensor of a continuous glucose monitoring device (CGM;
Paradigm Revel 523, MedTronic Mini-Med, Northridge, CA,
USA) in the patients' abdomen wall paying attention to avoid
locations that are constrained by clothing or accessories, or
are subjected to vigorous movement during exercise. In
accordance with the manufacturer's instructions for use, 2 h
after the sensorwas installed (and before the start of exercise),
a capillary glucose valuewas uploaded for calibration. Healthy
control subjects had only breakfast at 7:30 AM, which
included their usual average CHO intake (~0.7 g·kg−1). There-
after, all participants rested in an armchair.
About 45 min prior to the start of the exercise, the
volunteers were equipped with the belt of a heart rate
838 M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L 6 2 ( 2 0 1 3 ) 8 3 6 – 8 4 4monitoring system (Polar Electro, Kempele, Finland) to
acquire HR values every 15 s throughout the whole exercise.
Immediately thereafter, an indwelling catheter was inserted
into a forearm vein of the subjects; patency of the catheter
was maintained by intermittent flushing with saline.
To counter an excessive fall of glycemia, the algorithm
recently proposed by our workgroup was applied every half an
hour of exercise [21,35], and the estimated amounts of CHO
were administered to the patients in the form of fruit fudge
(Perugina, Italy; 93% sucrose). In brief, the algorithm first
estimates the overall amount of glucose burned on the basis
of the expected HR and exercise duration (in our case 30 min
for all periods). This quantity was then arbitrarily reduced by
8%, 16%, 23%, 30% and 34% [46] to calculate the CHO
requirement for the second to the sixth half-of-an-hour
exercise period, respectively. According to the algorithm, the
amount of CHO required to minimize the risk of hypoglyce-
mia is a percentage of the overall amount of glucose burned,
which depends on insulin concentration, which, in turn, is
estimated on the basis of the type and dose of administered
insulin and the time elapsed from the injection. Finally, the
algorithm takes into account the possible excess/lack of
glucose solved in the body by considering actual glycemia at
the start of the exercise. Accordingly, glycemia as measured
by means of the reactive strips before the start of the trial and
at the end of every 30 min duration of exercise was used. The
patients were thus given 0.14±0.11 g · kg−1 (range 0.0–
0.4 g·kg−1) of sucrose in the form of fruit fudge before the
start of the exercise. Thereafter, additional amounts of the
same fruit fudge were administered to patients for each of the
following half an hour of exercise periods. In addition,
whenever glycemia was below 5.0 mmol ·L−1, to rapidly
restore a safe blood glucose level, 10 mL of 33% w/v glucose
solution was infused. Overall, the patients received an
amount of sucrose and/or infused glucose in the range of
0.0–0.4 g·kg−1 every half an hour of exercise. No CHO were
given to the control subjects. All volunteers were allowed to
drink water ad libitum.
All the volunteers performed a 3-h (from 10:00 AM to
1:00 PM) constant HR exercise on a treadmill (Saturn, H-P
Cosmos, Traunstein, Germany). The target HR was kept
constant by automatically adjusting the speed and/or slope.
To minimize dizziness due to prolonged treadmill exercise, a
5-min rest was allowed at the end of each hour of exercise.
Work intensity was set to 30% of individual HR reserve
(HRtarget=HRrest+(HRmax − HRrest) ·0.3), corresponding to an
average target HR of 102±4 bpm, which reasonably guaran-
teed that all the subjects could complete the task. In addition,
the risk of exercise-related hypoglycemia in patients would
probably be increased by higher work intensities.
Oxygen consumption, carbon dioxide production, and
ventilation were measured breath-by-breath by means of a
metabolic unit (Quak b2, Cosmed, Rome, Italy) at rest, before
the start of the trial, and during the 10 central min of each half
of an hour period of the exercise.
Venous blood (~5 mL) was drawn 30 min prior to and at
subsequent 30 min intervals until the end of the exercise. In
diabetic subjects, a drop of blood collected was used to
immediately test glycemia using reactive strips (ContourLink,
Bayer Healthcare Diabetes Division); in addition, wheneverthe glucose level displayed on the receiver of the CGM was
falling quickly, the same strips were used to further test
glycemia from finger-stick capillary blood.
At the end of the exercises, the healthy control subjects
were free to leave the laboratory. In contrast, to minimize the
risk of late-onset hypoglycemic events, the patients were kept
under supervision of a physician trained in diabetes and an
expert nurse until the following morning. This time interval
was considered sufficient to minimize the risk of severe late-
onset hypoglycemic events. Indeed, it is known that even if
there is evidence that physical activity can affect insulin
sensitivity up to 48 h [58], inwell-insulinized patients, the pre-
exercise muscle glycogen level is restored to about 91% after
12 h recovery [59]. During their recovery period, our patients
received their usual insulin doses and meals for lunch and
dinner (at 1:30 PM and 7:30 PM, respectively). They were
allowed to sit quietly in an armchair (or lie in bed) while
their glucose level was tested using reactive strips every hour
until bedtime and, thereafter, at least at 2:00 AM and 5:00 AM.
In addition, whenever the CGM readings showed glucose
levels below 5.0 mmol·L−1 with a decreasing pattern, the
value was checked by a fingerstick capillary measurement,
and the infusion of a 5% glucose solutionwas started if the low
glycemic value was confirmed. At 7:00 AM, the sensor of CGM
was removed. All the glycemic levels were recorded on
appropriate forms, and its analysis confirmed that the
occurrence of late-onset hypoglycemia after the trials was
actually avoided in all cases.
2.3. Analyses
A drop of the blood drawn was used to determine lactate
concentration by means of reactive strips (Lactate Pro LT-
1710, Arkray, Kyoto, Japan) and to test glycemia in the
patients (ContourLink, Bayer Healthcare Diabetes Division).
The remaining blood was divided into a 2-mL Vacutainer
tube (#368920) containing a glycolysis inhibitor (4 mg of
kalium oxalate+5 mg of sodium fluoride) and a 3.5-mL
Vacutainer SST™ II advance tube (#368965) with gel and
clot activator. Immediately thereafter, both the tubes were
gently inverted and stored at +4 °C until the hospital
laboratory centrifuged the samples to separate serum and
perform the measurements.
Plasma glucose concentration was determined by applying
a hexokinase-based methodology (Olympus Diagnostic Sys-
tems AU2700), and our determined coefficient of analytical
variation was <2% in the range of 3.27–11.67 mmol ·L−1.
Cortisol and growth hormone (hGH) were measured using
the Siemens Healthcare Diagnostics (Deerfield, IL, USA)
automated immunoassay systems (ADVIA Centaur, and
Immulite 2000, respectively) by employing original reagents
for both determinations; the coefficient of analytical variation
was <5% in the range of 155–1025 nmol·L−1 for cortisol and
<2% in the range of 2.6–17 ng·mL−1 for hGH. Insulin concen-
trations were determined by means of the Beckman Access 2
Automated Immunoassay system (Beckman Coulter, Fuller-
ton, CA); coefficient of analytical variation was <6% in the
range of 73.9–327.5 pmol·L−1. This insulin assay was chosen
because itmeasures all the relevant insulin analogs showing a
cross-reactivity of about 80% [60].
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HR data were downloaded to a personal computer and
averaged offline over 15-min periods.
Oxygen consumption (V˙O2) and carbon dioxide production
(V˙CO2) data were averaged over the corresponding 10-min
recording periods. These averaged data allowed us to calculate
the respiratory quotient, assumed to be equal to the respira-
tory exchange ratio (RER). Hence, by assuming that proteins do
not contribute to any significant extent to the energy
production during exercise [61,62] the whole-body glucose
(GLUox) and fat oxidation rates as well as the total energy
expenditure were estimated by applying commonly used
equations [63]. The amount of energy yield by the oxidation
of CHO was subsequently computed by assuming an energy
potential of 3.95 kcal ·g−1 [61].
Finally, the CHO oxidation rates observed in the diabetic
subjects, expressed as the percentage of the first value (i.e.,
the value during the 10–20 min exercise period), were
modeled as follows:
Perc tð Þ ¼ CHO 0ð Þ−ΔCHO⋅ 1−e−tτ
 
where CHO(0) is the estimated percentage GLUox at the actual
start of exercise, ΔCHO is the percentage decrease in the
oxidation rate at the asymptote, and τ is the time constant of
the time course (expressed in min).
2.5. Statistical analysis
The data were analyzed using standard statistical methods
(Systat vs. 11). Two-way analysis of variance with repeated
measures design (MANOVA, with study group and gender as
between-subjects factor and time as within-subjects factor)
was applied, followed by specific contrasts when appropriate.
To appropriately use the repeated measure analysis of
variance, Mauchly's test was used to check if the sphericity
assumption appeared to be violated, i.e. if the variances of the
differences between all possible pairs of groups were not
equal. In instances where Mauchly's test was significant,
modification had to be made to the degrees of freedom. The
Greenhouse–Geisser ε provides a measure of departure from
sphericity, and can be used to adjust the degrees of freedom.Table 2 – Physiological characteristics of the two study groups
Rest 15 min 45 mi
Diabetic Patients
Heart rate (bpm) 72.5±6.8 101.8±7.0 101.5±4
Progression speed (m·s−1) – 1.4±0.2 1.4±0
V˙O2 (mL·min−1·kg−1) 4.0±0.6 13.9±3.3 13.5±3
V˙CO2 (mL·min−1·kg−1) 3.5±0.5 12.3±3.0 11.7±2
RER 0.84±0.03 0.89±0.03 0.87±0
Control Subjects
Heart rate (bpm) 73.0±3.6 102.3±3.7 101.9±4
Progression speed (m·s−1) – 1.5±0.2 1.5±0
V˙O2 (mL·min−1·kg−1) 4.2±0.5 14.6±3.0 14.1±2
V˙CO2 (mL·min−1·kg−1) 3.8±0.5 13.0±2.9 12.1±2
RER 0.86±0.04 0.89±0.03 0.86±0In fact, when sphericity is exactly met, then epsilon will be
exactly 1, and if sphericity is violated, then epsilon will be<1;
the further the epsilon is from 1, the worse is the violation. A p
value of<0.05 was assumed as statistically significant. Data
are expressed as means±SD.3. Results
The respiratory data at rest and during the 3-h exercise for
both T1DM patients and healthy volunteers are summarized
in Table 2. The actual HR during the exercises was not
significantly different between T1DM patients and healthy
controls (group effect, F=0.028, p=NS), or between genders
(gender effect, F=2.803, p=NS), amounting to an average of
101±5 bpm. It reached the target value in a few minutes, and
thereafter remained stable over time in both the groups (time
effect, F=1.460, p=NS; group × time effect, F=0.566, p=NS).
Progression speed was not significantly different between
T1DM patients and controls (group effect, F=1.740, p=NS), but
was significantly lower in women, when compared with men
(gender effect, F=4.763, p<0.05); it decreased slightly during
the exercises from 1.5 ± 0.2 to 1.4 ± 0.2 m·s−1, even if the
decline was not statistically significant (time effect, F=1.513,
p=NS). Oxygen consumption (V˙O2), expressed per unit body
mass, was not significantly different between diabetic pa-
tients and healthy controls (group effect, F=0.146, p=NS;
group × time effect, F=1.814, p=NS), but was significantly
lower in women, when compared with men (gender effect, F=
8.423, p<0.05).V˙O2 decreased slightly during the 3-h exercise
from 14.3±3.1 mL·min−1 ·kg−1 to 12.8±3.6 mL·min−1 ·kg−1
(time effect, F=4.320, p<0.01). The overall energy expenditure
for 3-h exercise was not significantly different between the
T1DM patients and controls (un-paired t-test, P=NS), amount-
ing to 3238±970 kJ and 3628±974 kJ in patients and healthy
controls, respectively. The overall amounts of sucrose and
infused glucose administered to patients remained constant
over time (time effect, F=0.669, p=NS), amounting to an
average of 0.13±0.11 g·kg−1.
GLUox, expressed per unit bodymass, is illustrated in Fig. 1
as a function of exercise duration. GLUox decreased signifi-
cantly with increasing exercise duration (time effect, F=
52.224, p<0.001), but no significant difference could beat rest and during the 3 h walks.
n 75 min 105 min 135 min 165 min
.9 100.6±8.3 101.9±6.9 100.7±6.4 101.3±4.3
.1 1.4±0.2 1.4±0.2 1.4±0.1 1.4±0.2
.3 12.9±3.3 12.9±3.4 12.8±3.5 13.2±4.1
.8 11.0±2.8 10.9±3.0 10.7±2.9 10.8±3.3
.03 0.85±0.03 0.84±0.03 0.83±0.03 0.82±0.03
.5 100.3±1.4 102.3±3.6 102.5±3.4 102.1±2.6
.1 1.5±0.1 1.5±0.2 1.5±0.1 1.4±0.2
.9 14.1±3.6 13.5±2.7 13.7±2.9 12.3±3.2
.8 11.9±3.2 11.1±2.4 11.1±2.6 10.1±2.8
.03 0.84±0.02 0.82±0.03 0.81±0.03 0.82±0.03
Fig. 1 – Time course of the glucose oxidation rate in the T1DM
patients (full dots) and in the healthy control subjects (open
dots). Glucose oxidation rate decreased significantly with
increasing exercise duration (p<0.001), but the two groups of
volunteers were not significantly different.
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F=0.007, p=NS; group × time effect, F=1.571, p=NS). Further-
more, a tendency towards a lower GLUox in women wasFig. 2 – Time course of the insulin concentration (panel A) in
the two groups of volunteers. Insulin concentration decreased
significantly during the trial in both groups (p<0.005) but was
significantly higher in patients across thewhole experimental
period (p<0.001). Time course of the blood glucose level (panel
B) in the two groups of volunteers. Glycemia was significantly
higher in the diabetic patients (p<0.005); it decreased signif-
icantly during the exercises (p<0.05), following a different
behavior in the two groups (p<0.01). In both panels: full dots=
T1DM patients; open dots=healthy control subjects.observed (gender effect, F=3.589, p=0.083). The percentage
energy yielded by glucose oxidation during the 3-h exercise
was not significantly different between T1DM patients and
healthy volunteers (group effect, F=0.721, p=NS) or between
the genders (gender effect, F=0.002, p=NS). Overall, the
percentage energy from glucose oxidation decreased from
67.0%±8.8% during the first half an hour to 42.7%±10.9%
during the last half an hour of exercise (time effect, F=55.182,
p<0.001), showing a similar behavior in patients and controls
(group × time effect, F=1.535, p=NS).
Fig. 2A illustrates the average insulin concentrations
(pmol·L−1) of diabetic patients and controls during the trials.
Insulin concentrationwas significantly higher in patients across
the whole experimental period (group effect, F=216.1, p<0.001).
In both the groups, the insulin concentration decreased
significantly during the trial (time effect, F=8.209, p<0.005).
Glycemia (Fig. 2B) was significantly higher in the patients
(group effect, F=16.10, p<0.005), but decreased significantly
during the exercises (time effect, F=4.700, p<0.05), following a
different behavior in the two groups (group × time effect, F=
6.443, p<0.01). The patients’ glycemia decreased on averageFig. 3 – Time course of the concentration of growth hormone
(hGH; panel A) in the two groups of volunteers. Growth
hormone concentration showed a similar behavior in the two
groups (group effect, F=1.038, p=NS; group × time effect, F=
1.873, p=NS), peak values being observed after the first hour of
exercise (difference contrast, F=6.688, p<0.05). Time course of
the concentrationof cortisol in blood (panel B) in the twogroups
of volunteers. Cortisol concentration changed throughout the
3-h exercise (p<0.001), but did not show any significant
difference between the two study groups. In both panels: full
dots=T1DM patients; open dots=healthy control subjects.
Fig. 4 – Individual carbohydrate oxidation rates observed in
the diabetic subjects, expressed as percentage of the first
value (corresponding to the oxidation rate during the 10–
20 min exercise period) are illustrated as a function of
exercise duration. The exponential equation describing the
data is as follows:
Perc tð Þ ¼ 109:2−62:2 ð1−e−t90Þ
(n=96; mean corrected R2=0.666).
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to 6.3±1.5 mmol · L−1 at the very end of the exercises;
conversely, healthy volunteers showed a rather stable value
of about 4.7±0.5 mmol·L−1.
Lactate concentration slightly decreased during the exer-
cises (time effect, F=7.867, p<0.001) from 1.15±0.24 mmol·L−1
at the start of the exercises to 0.91±0.17 mmol·L−1 at the end
of the exercises, without any significant difference between
the two groups of volunteers (group effect, F=3.401, p=NS;
group × time effect, F=0.494, p=NS).
The concentration of growth hormone (Fig. 3A) showed
a similar behavior in the two groups (group effect, F=1.038,
p=NS; group × time effect, F=1.873, p=NS), increasing
significantly during the first hour of exercise (difference
contrast, F=6.688, p<0.05). On the other hand, cortisol
concentration (Fig. 3B) was not significantly different between
the two study groups (group effect, F=0.063, p=NS); it changed
during the 3-h exercise (time effect, F=6.634, p<0.001),
without any difference between patients and healthy controls
(time × group effect, F=0.582, p=NS).
Individual GLUox values for both the groups, expressed as
percentage of the appropriate first value (i.e., the value of the
10–20 min exercise period was taken as 100%), are illustrated
in Fig. 4 as a function of exercise duration. The fitting
procedure yielded the following exponential equation:
Perc tð Þ ¼ 109:2−62:2⋅ 1−e−t90
 
(n=96; mean corrected R2=0.666).4. Discussion
The present study showed that during prolonged exercise, the
time course of GLUox in T1DMpatients exercising under usualtherapy and diet was not significantly different from the
oxidation rates observed in the control subjects. Despite the
administration of fruit fudge required by T1DM patients to
avoid an excessive fall of glycemia, a very similar time-
dependent decrease in GLUoxwas observed in the two groups,
which is in agreement with previous studies [64,65]. Similar
GLUox values (and the contribution to total energy yield) were
also observed between the controls and diabetic patients
during shorter aerobic exercises (≤ 1-h duration) [31,41].
Indeed, increased extracellular glucose availability, does not
translate into increased intracellular GLUox [37,40]. At vari-
ance, T1DM patients exercising under high insulin infusion
rates showed a slightly increased whole-body CHO oxidation
rate [39]. Nevertheless, patients exercising under four signif-
icantly different insulin concentrations behaved metabolical-
ly similar to healthy people, suggesting that GLUox is not
directly related to blood insulin concentration [66].
In response to the prolonged exercise, T1DM patients
showed a higher hGH stimulation (though not significant),
when compared with healthy control subjects, with peak
values observed after about 1 h of exercise. Despite the less
stable glycemia, the average increase in hGH concentration is
found to be in agreement with previous observations [67]. The
administration of an oral glucose bolus before exercise
resulted in a blunted hGH response in both healthy volunteers
and T1DM patients [68]. In the present investigation, fruit
fudge was administered to patients prior to / during the
exercises to counter an excessive fall of glycemia, which
might have reduced the counter-regulatory response of hGH.
Some “noise” might have been introduced in our results,
which, however, reflect the usual life conditions of patients.
No significant difference between T1DM patients and
healthy controls was found for cortisol concentration. The
observed pattern of cortisol concentration is in agreement
with the known circadian rhythm with peak levels noted
early in the morning [69,70]. In addition, it also suggests that
the exercise intensity chosen for the present study did not
induce an important stress in the body. In fact, in view of the
prolonged duration of the exercise (3-h), the selected
progression speed was slightly lower than the mean brisk
walking speed observed in a group of recreational walkers
[71]. Under hyperglycemic conditions, Jenni et al. [37]
observed similar cortisol levels at the start and end of
exercises performed by a group of T1DM patients. The
authors claimed a blunted cortisol secretion to explain the
higher GLUox observed under hyperglycemia. Indeed, corti-
sol, together with hGH, has been found to induce peripheral
lipolysis [72], which in turn may play a role in the shift
towards lipid oxidation. In agreement with previous results
[65], T1DM patients of the present investigation showed
similar GLUox, when compared with healthy volunteers,
despite their higher blood glucose and insulin levels. It can be
hypothesized that the higher GLUox observed under hyper-
glycemia by Jenni et al. [37] might be the consequence, at
least in part, of the higher insulin concentration maintained
during their clamp procedures. The evidence of a higher
GLUox in T1DM patients exercising under high insulin levels
[39] supports this hypothesis.
The main strength of the current study is that the T1DM
patients were studied under their usual metabolic conditions,
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their glucose levels. In addition, in the present investigation
HR was held constant throughout the exercises instead of
intensity, to mimic outdoor physical activities, during which
HR is the most commonly used index of exercise intensity.
The automatic adjustments of progression speed during the
exercises allowed us to achieve a constant HR throughout the
trials. As expected, GLUox decreased during exercise, due to
the combined effect of exercise duration and of the reduced
progression speed. However, even if progression speed
decreased slightly from the start to the end of the exercises,
this change was not statistically significant, suggesting that
the decrease in GLUox was mainly due to the exercise
duration effect. Considering all the above-mentioned condi-
tions, we are confident that our experimental protocol yielded
results that can be directly employed to draw concrete
suggestions for T1DM patients to avoid excessive falls of
glycemia during exercise.
The present investigation is not without some limitations.
Indeed, despite the fact that we were aware that women rely
more on fat oxidation than men [51–54] and that substrate
utilization in females is also influenced by the hormonal
status [55–57], our study groups were composed of quite
diverse subjects and no particular attention was paid to the
menstrual cycle phase of women. The heterogeneity in the
recruited volunteers might probably have introduced some
noise in the obtained results. Nevertheless, the percentage
energy yielded by glucose oxidation was not significantly
different between the genders, giving us confidence that the
proposed mathematical description of the behavior of GLUox
is actually applicable in almost all conditions (e.g., indepen-
dent of gender and the menstrual cycle phase). Finally, no
tracers were used to specifically depict the contribution of the
endogenous glucose production [e.g., [14,37]] or of the
exogenous GLUox [e.g., [41]] on the whole-body GLUox.
However, the main purpose of the present investigation was
to study whole-body GLUox.
Our workgroup has recently developed an algorithm
(ECRES; Exercise Carbohydrate Requirement Estimating Soft-
ware) [21,35], which helps the T1DM patients to determine,
on a patient- and situation-specific basis, the amount of
CHO that they need before and/or during moderate aerobic
exercise to maintain blood glucose levels within the
recommended range, i.e. 3.9–10.0 mmol·L−1 [73], thus min-
imizing the risk of immediate exercise-induced glycemic
imbalances. Of note, as a reduction in the premeal insulin
dose has been proposed to counter the risk of an excessive
exercise-induced fall of blood glucose [74,75], the algorithm
has been designed to also take into account occasional
changes in the usual therapy, e.g., the reduced insulin doses
in anticipation of exercise. This strategy, however, often
does not exempt patients from a CHO supplement [18]. The
algorithm is based on the observation that the amount of
CHO needed to prevent hypoglycemia is strictly related to
insulin concentration and represents a fraction of the
overall amount of glucose burned during the exercise [66].
In turn, the overall amount of glucose oxidized during the
effort may be estimated on the basis of the expected
exercise intensity (defined by HR) [36]. This algorithm
unfolds the prospect of a method to estimate the amountof CHO required by a T1DM patient to minimize exercise-
induced glycemic imbalances, given the overall amount of
glucose oxidized is correctly predicted. Nevertheless, to date,
it has not been possible to estimate GLUox taking into
account the exercise duration as well, because no mathe-
matical equations were available describing the time course
of the CHO oxidation rate during prolonged exercise. The
present investigation yields an exponential function de-
scribing the behavior of GLUox, expressed as the percentage
of the first value (i.e., the value of the 10–20 min exercise
period taken as 100%), as a function of exercise duration.
Indeed, the relationship between GLUox and duration of
exercise could also be well described by other mathematical
functions, yielding very similar correlation coefficients.
Nevertheless, an exponential description was chosen, hy-
pothesizing that GLUox reaches a stable asymptotic value
for very prolonged exercises. The proposed equation will be
introduced in the aforementioned algorithm [21], thus
allowing to correct the estimated amount of glucose burned
during exercise according to its duration, and consequently
enhancing the performance of the algorithm for prolonged
exercise conditions. In its current version, our algorithm
seemed adequate for estimating the supplemental CHO
required by a T1DM patient to avoid immediate exercise-
induced glycemic imbalances in about 70% of the exercises,
independent of the time of day when the activity was
performed [21,35]. Several different implementations of the
algorithm can be foreseen, ranging from software imple-
mentations for single patient's use to web-based solutions.
The algorithm can also be easily integrated into many
different devices, such as training equipment or glucose
monitoring systems. Finally, a real-time version of the
algorithm, implemented on a portable device and designed
to estimate in real time the residual supplemental CHO still
available during exercise on the basis of actual HR (acquiring
data similarly to the commercial HR monitors), will be a
very intriguing device able to warn patients of the actual
risk of hypoglycemia during their physical activities. This
solution may be of very simple use, liberating the patients
from the need of understanding in some detail the
metabolic responses to exercise and allowing them to safely
enjoy the benefits of physical activity.
In conclusion, the present investigation provides evidence
that under usual life conditions, GLUox in T1DM patients
shows the same time-dependent decreases as those noted in
healthy people, and can be well described by an exponential
function. The proposed equation, introduced in the recently
developed algorithm [21], will allow to correct the estimated
amount of glucose burned during exercise according to its
duration, thus enhancing the estimate of the amount of CHO
required to avoid hypoglycemia.Author contributions
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